Precision Therapeutics Plans IPO
August 28, 2007
Precision Therapeutics, Inc. plans an initial public offering of its common stock, according to a regulatory filing Friday with the Securities and Exchange Commission. The company did not disclose the expected number or price range of shares to be offered, but indicated the offering price could total up to $80.5 million (that figure was an estimate used to calculate the registration fee and is subject to change). Precision develops tests to help physicians individualize cancer therapy. JP Morgan Securities, Piper Jaffray & Co, and JMP Securities are underwriting the offering.
« Landslide: "One to Watch" | | DFJ Network Profiled in Private Equity International »
